A novel biomarker, ROS/ATP ratio, accurately predicts drugs associated with serious drug induced liver injury (sDILI)
Publication
, Conference
Zhang, J; Suzuki, A; Kelly, R; Fang, H; Li, AP; Tong, W
Published in: HEPATOLOGY
2012
Duke Scholars
Published In
HEPATOLOGY
ISSN
0270-9139
Publication Date
2012
Volume
56
Issue
6
Start / End Page
1523 / 1524
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics
Citation
APA
Chicago
ICMJE
MLA
NLM
Zhang, J., Suzuki, A., Kelly, R., Fang, H., Li, A. P., & Tong, W. (2012). A novel biomarker, ROS/ATP ratio, accurately predicts drugs associated with serious drug induced liver injury (sDILI). In HEPATOLOGY (Vol. 56, pp. 1523–1524).
Zhang, Jie, Ayako Suzuki, Reagan Kelly, Hong Fang, Albert P. Li, and Weida Tong. “A novel biomarker, ROS/ATP ratio, accurately predicts drugs associated with serious drug induced liver injury (sDILI).” In HEPATOLOGY, 56:1523–24, 2012.
Zhang J, Suzuki A, Kelly R, Fang H, Li AP, Tong W. A novel biomarker, ROS/ATP ratio, accurately predicts drugs associated with serious drug induced liver injury (sDILI). In: HEPATOLOGY. 2012. p. 1523–4.
Zhang, Jie, et al. “A novel biomarker, ROS/ATP ratio, accurately predicts drugs associated with serious drug induced liver injury (sDILI).” HEPATOLOGY, vol. 56, no. 6, 2012, pp. 1523–24.
Zhang J, Suzuki A, Kelly R, Fang H, Li AP, Tong W. A novel biomarker, ROS/ATP ratio, accurately predicts drugs associated with serious drug induced liver injury (sDILI). HEPATOLOGY. 2012. p. 1523–1524.
Published In
HEPATOLOGY
ISSN
0270-9139
Publication Date
2012
Volume
56
Issue
6
Start / End Page
1523 / 1524
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics